Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Curr Pharm Biotechnol ; 24(13): 1694-1707, 2023.
Article in English | MEDLINE | ID: mdl-36856179

ABSTRACT

BACKGROUND: The treatment of diabetes with plant ingredients such as in Traditional Chinese Medicine (TCM) is an alternative to classical chemotherapy. OBJECTIVE: This study aims to explore the hypoglycemic effect of Trichosanthes pericarpium powder (TP) and intestinal bacteria transplantation in type 2 diabetic mice. The relationship between intestinal bacteria transplantation and improvement in insulin resistance was also investigated. METHODS: The polyphenols and terpenoids in the TP were identified by LC-MS/MS. Streptozotocin was used to induce a mouse model of type 2 diabetes. Diabetic mice were treated with different doses of TP and the intestinal bacteria obtained from the high-dose TP group for four weeks. RESULTS: As a result, FBG levels were found to be significantly reduced in diabetic mice, weight gain and organ enlargement were alleviated, and insulin resistance was significantly improved. TP administration also improved the disorder in intestinal bacteria in diabetic mice. Besides, TP can increase the liver AMPK, SIRT1, GLUT1, and GLUT4 gene expression, while down-regulated PEPCK and G6Pase gene expression suggest a potential mechanism for hypoglycemia in diabetic mice. CONCLUSION: Oral administration of Trichosanthes pericarpium powder in the treatment of diabetes may be achieved by restoring hepatic function, improving insulin resistance, and the dynamic balance of intestinal bacteria.


Subject(s)
Diabetes Mellitus, Experimental , Diabetes Mellitus, Type 2 , Insulin Resistance , Trichosanthes , Mice , Animals , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/therapeutic use , Diabetes Mellitus, Type 2/drug therapy , Trichosanthes/metabolism , Diabetes Mellitus, Experimental/drug therapy , Chromatography, Liquid , Powders/metabolism , Powders/pharmacology , Powders/therapeutic use , Blood Glucose/metabolism , Tandem Mass Spectrometry , Bacteria/metabolism , Insulin/metabolism , Liver
2.
Foods ; 12(4)2023 Feb 09.
Article in English | MEDLINE | ID: mdl-36832842

ABSTRACT

Diabetes can cause severe kidney disease. Euryale ferox seeds (Gordon Euryale) have known antioxidant, hypoglycemic, and renal protection effects. Methanol extracts of Gordon Euryale were produced from ungerminated and germinated seeds. The effect of germination on polyphenol and flavonoid content was investigated by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. Three doses of ungerminated seed extract (EKE) and germinated seed extract (GEKE) were administered to diabetic mice by gavage to explore the treatment-dependent improvement of oxidative stress, metabolic disorder, and kidney disease. Seed germination led to a 1.7 times increase in total phenol content in the extract, and the flavonoid content was increased by 1.9 times. Germination greatly increased the contents of 29 polyphenols and 1 terpenoid. At the same dose, GEKE more strongly improved hyperglycemia, abnormal lipid metabolism, and renal tissue lesions (as confirmed by histology) in the diabetic mice than EKE did. In diabetic mice receiving treatment, kidney microalbunminuria (ALB), blood urea nitrogen (BUN), serum creatinine (Scr), malondialdehyde (MDA), and glutathione (GSH) were all decreased, while activity of catalase (CAT), superoxide dismutase (SOD), and serum total antioxidant capacity (T-AOC) were increased. Both EKE and GEKE can improve diabetes and kidney disease by improving hyperglycemia, oxidative stress, and kidney physiological indicators and regulating the Keap1/Nrf2/HO-1 and AMPK/mTOR pathways. However, in both pathways, GEKE is more effective. The purpose of this study was to explore the effects of GEKE and EKE treatment on antioxidant defense and metabolic capacity of diabetic animals. Germination provides a suitable strategy to improve the medicinal value of these natural plant-based products.

3.
Molecules ; 28(2)2023 Jan 05.
Article in English | MEDLINE | ID: mdl-36677586

ABSTRACT

The polysaccharides isolated and purified from different parts of the medicinal fungus Cordyceps cicadae were identified, and three extracts displaying significant biological activities were selected for further study. The bacterium substance polysaccharides (BSP), spore powder polysaccharides (SPP), and pure powder polysaccharides (PPP) were separated, purified, and collected from the sclerotia, spores, and fruiting bodies of Cordyceps cicadae, respectively. The structures of Cordyceps cicadae polysaccharides were analyzed using gas chromatography, Fourier-transform infrared spectroscopy, methylation analysis, and one-dimensional (1H and 13C) nuclear magnetic resonance spectroscopy. Moreover, the hypoglycemic effect of Cordyceps cicadae polysaccharides was examined in both in vitro and in vivo models. BSP, SPP, and PPP significantly increased glucose absorption in HepG2 cells, and alleviated insulin resistance (IR) in the in vitro model. SPP was the most effective, and was therefore selected for further study of its hypoglycemic effect in vivo. SPP effectively improved body weight and glucose and lipid metabolism in type 2 diabetes model mice, in addition to exerting a protective effect on liver injury. SPP regulated the mRNA expression of key PI3K/Akt genes involved in the insulin signaling pathway. The hypoglycemic mechanism of SPP may reduce hepatic insulin resistance by activating the PI3K/Akt signaling pathway. Spore powder polysaccharides (SPP) extracted from Cordyceps cicadae effectively improved body weight and glucose and lipid metabolism in type 2 diabetes model mice, in addition to exerting a protective effect on liver injury. The mechanism underlying the hypoglycemic effect of SPP regulates the mRNA expression of key PI3K/Akt genes involved in the insulin signaling pathway to alleviate insulin resistance. Our results provide a theoretical basis for research into the hypoglycemic effect of Cordyceps cicadae, and lay the foundation for the development of functional products.


Subject(s)
Cordyceps , Diabetes Mellitus, Type 2 , Insulin Resistance , Mice , Animals , Hypoglycemic Agents/pharmacology , Phosphatidylinositol 3-Kinases , Powders , Proto-Oncogene Proteins c-akt , Polysaccharides/chemistry , Cordyceps/chemistry , Insulin , Glucose , RNA, Messenger
4.
J Sci Food Agric ; 100(5): 2074-2081, 2020 Mar 30.
Article in English | MEDLINE | ID: mdl-31875960

ABSTRACT

BACKGROUND: A mouse model in which diabetes mellitus was induced by low-dose streptozotocin (STZ) injection combined with a high-fat diet was used to study the effect of two water cress (Lepidium savitum) preparations. Diabetic mice were treated with dried cress powder or with water-soluble extracts (tested at two doses), together with proper control groups. The mice were evaluated after 4 weeks of continuous intervention for type 2 diabetic and associated markers. We determined blood glucose, body weight, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), serum insulin levels, and DNA integrity of hepatic cells. The concentrations of malondialdehyde (MDA) and lipid peroxide (LPO) and the activities of four enzymes that are part of the antioxidant defense system were determined in liver samples, as well as gene expression (by semi-quantitative reverse transcription polymerase chain reaction) and enzyme activity of IRS-1, IRS-2, PI3K, AKT-2, and GLUT4. RESULTS: After 4 weeks of intervention, the levels of TC, TG, and LDL cholesterol were significantly (P < 0.5) decreased and HDL cholesterol was significantly increased. Enzyme activities of liver superoxide dismutase, glutathione, glutathione peroxidase, and catalase were significantly increased, whereas MDA and LPO concentrations were significantly reduced. The transcription level of the five genes assessed was increased, with corresponding increases in protein expression. CONCLUSION: Oral uptake of garden cress can significantly reduce the blood glucose and improve the blood lipid metabolism of diabetic mice. Considerable improvements in the activity of antioxidant defense enzymes were observed in type 2 diabetic mice that improved the body's antioxidant emergency response. © 2019 Society of Chemical Industry.


Subject(s)
Blood Glucose/metabolism , Diet, High-Fat , Lepidium sativum/chemistry , Lipids/blood , Animals , Antioxidants/metabolism , Catalase/metabolism , Cholesterol, HDL/blood , Cholesterol, LDL/blood , DNA Fragmentation , Diabetes Mellitus, Experimental/prevention & control , Gene Expression Regulation , Glucose Transporter Type 4/genetics , Glucose Transporter Type 4/metabolism , Glutathione/metabolism , Glutathione Peroxidase/metabolism , Glycated Hemoglobin/metabolism , Hypoglycemic Agents/pharmacology , Insulin/blood , Insulin Receptor Substrate Proteins/genetics , Insulin Receptor Substrate Proteins/metabolism , Lipid Peroxides/metabolism , Male , Malondialdehyde/metabolism , Mice , Mice, Inbred ICR , Oxidative Stress/drug effects , Phosphatidylinositol 3-Kinases/genetics , Phosphatidylinositol 3-Kinases/metabolism , Plant Extracts/pharmacology , Superoxide Dismutase/metabolism , Triglycerides/blood
5.
Pak J Pharm Sci ; 32(5): 2011-2017, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31813865

ABSTRACT

In this paper, we investigated the effects of protein from sea buckthorn seed on the expression of genes involved in liver glucose metabolism and on the activation of the AMPK/SIRT1 pathway in streptozotocin (STZ)-induced diabetic ICR mice. The investigated factors included oral glucose tolerance test, insulin resistance, insulin sensitivity index, AMPK and SIRT1 activity and the expression of liver glucose metabolism genes. Seabuckthorn seed protein (SSP) improved the oral glucose tolerance and insulin sensitivity, reduced insulin resistance, suppressed expression of liver glucose metabolism genes and upregulated activation of the AMPK/SIRT1 pathway. Therefore, the results demonstrate that SSP can improve insulin resistance, suppress expression of these genes and upregulate activation on the AMPK /SIRT1 pathway in STZ-induced diabetic ICR mice.


Subject(s)
Blood Glucose/drug effects , Diabetes Mellitus, Experimental/drug therapy , Glucose/metabolism , Hippophae/chemistry , Hypoglycemic Agents/pharmacology , Seeds/chemistry , Animals , Carbohydrate Metabolism/drug effects , Diabetes Mellitus, Experimental/chemically induced , Diabetes Mellitus, Experimental/metabolism , Insulin/metabolism , Insulin Resistance/physiology , Male , Mice , Mice, Inbred ICR , Sirtuin 1/metabolism , Streptozocin/pharmacology
6.
Int J Biol Macromol ; 107(Pt A): 1168-1174, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28951300

ABSTRACT

This study investigated the intestinal microbial community distribution of Type 2 diabetic mice and discussed the effects of the sea buckthorn protein on the regulation of gut microbes. Date was collected for 12 cases of normal mice (NC group), 12 cases of Type 2 diabetic mice (DC group), and 12 cases of highly concentrated sea buckthorn seed protein dosed mice (SSPH group). This study analysed fecal samples, measured faecal pH value, and cultivated and determined intestinal bacteria count. This investigation also included the extraction of faecal samples for genomic DNA, PCR amplification of bacterial V3 16S rDNA products by denaturing gradient gel electrophoresis, DGGE map analysis of intestinal flora, determination of intestinal bacteria richness, Shannon-Wiener index and evenness index, and image similarity cluster analysis with UPGMA clustering. This study analysed and elucidated differences between the normal mice group, diabetic mice group, and sea buckthorn protein supplemented group, and the structures of respective intestinal flora. The mice supplemented with sea buckthorn protein exhibited an obvious drop in body weight and blood glucose levels. The Bifidobacterium, Lactobacillus, Bacteroides, and Clostridium coccoides populations recovered. The amplification of the 16S rDNA gene V3 region revealed that the species of intestinal microbes in the treatment group were adjusted to a certain extent. Analysis by ARDRA confirmed that sea buckthorn protein could increase type 2 diabetes in mice intestinal microorganism diversity (H) and simpson (E).


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Gastrointestinal Microbiome/drug effects , Hippophae/chemistry , Seed Storage Proteins/administration & dosage , Animals , Bacteroides/drug effects , Bacteroides/genetics , Bacteroides/isolation & purification , Bifidobacterium/drug effects , Bifidobacterium/genetics , Bifidobacterium/isolation & purification , Blood Glucose/drug effects , Clostridium/drug effects , Clostridium/genetics , Clostridium/isolation & purification , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/microbiology , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/microbiology , Feces/microbiology , Gastrointestinal Microbiome/genetics , Humans , Lactobacillus/drug effects , Lactobacillus/genetics , Lactobacillus/isolation & purification , Mice , Mice, Inbred NOD , RNA, Ribosomal, 16S/genetics , Seed Storage Proteins/chemistry
7.
Exp Ther Med ; 13(5): 2036-2042, 2017 May.
Article in English | MEDLINE | ID: mdl-28565805

ABSTRACT

In this study, the effects of different doses of dual modification-treated (DMT) indica rice resistant starch (IR-RS) on azoxymethane (AOM)-induced early colon cancer in mice were investigated. The investigated factors included body weight, gastrointestinal emptying rate, the number and morphology of aberrant crypt foci (ACFs) and the specific expressions of adenomatous polyposis coli (APC), B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and cytochrome c genes. The results demonstrated that DMT IR-RS controlled the increase in the body weights of the mice, increased the gastrointestinal emptying rates and reduced the numbers of ACFs and aberrant crypts. Reverse transcription-polymerase chain reaction revealed that DMT IR-RS promoted the expression of APC, Bax and cytochrome c and inhibited the expression of Bcl-2. These results demonstrate that a DMT IR-RS diet may induce apoptosis and has beneficial health effects in AOM-induced early colon cancer in mice.

8.
J Sci Food Agric ; 97(7): 2068-2074, 2017 May.
Article in English | MEDLINE | ID: mdl-27562375

ABSTRACT

BACKGROUND: Enteric dysbiosis is associated with chronic inflammation and interacts with obesity and insulin resistance. Obesity and diabetes are induced in ICR (Institute of Cancer Research) mice fed a high-fat diet and administered a streptozocin injection. These mice were treated with normal rice (NR), normal rice with a high resistant starch content (NRRS) or Se-rich rice (selenium-enriched rice) with a high resistant starch content (SRRS). RESULTS: Faecal cell counts of Bifidobacterium, Lactobacillus and Enterococcus were significantly higher in SRRS-treated mice than in diabetic controls, while Enterobacter cloacae were lower. Similar results were also found in NRRS-treated mice. In contrast, no significant difference was found between NR-treated and diabetic control groups. The treatments with SRRS and NRRS reduced the faecal pH values of the diabetic mice. Regarding the inflammatory factor levels, lower levels of serum C-reactive protein (CRP), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), nuclear factor-k-gene binding (NF-κB) and leptin (LEP) and higher adiponutrin (ADPN) levels were found in the SRRS and NRRS-treated mice compared with the diabetic and NR-treated mice. In addition, the CRP, IL-6 and NF-κB levels in the SRRS-treated mice were significantly reduced compared with those observed in the NRRS-treated mice. The reverse transcription-PCR (RT-PCR) results showed that the SRRS and NRRS-treated mice presented higher expression levels of orphan G protein-coupled receptor 41 (GPR41) and orphan G protein-coupled receptor 43 (GPR43) proteins compared with diabetic mice and NR-treated mice. CONCLUSION: These results indicate that treatments with rice high in RS exert beneficial effects by improving enteric dysbiosis and chronic inflammation. In addition, selenium and RS may exert synergistic effects on chronic inflammation. © 2016 Society of Chemical Industry.


Subject(s)
Diabetes Mellitus/diet therapy , Dysbiosis/diet therapy , Flour/analysis , Oryza/chemistry , Plant Extracts/administration & dosage , Selenium/administration & dosage , Starch/metabolism , Animals , Diabetes Mellitus/genetics , Diabetes Mellitus/immunology , Diabetes Mellitus/metabolism , Dysbiosis/genetics , Dysbiosis/immunology , Dysbiosis/metabolism , Humans , Interleukin-6/genetics , Interleukin-6/immunology , Male , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mice, Inbred ICR , NF-kappa B/genetics , NF-kappa B/immunology , Obesity/diet therapy , Obesity/genetics , Obesity/immunology , Obesity/metabolism , Oryza/metabolism , Plant Extracts/metabolism , Selenium/analysis , Starch/chemistry , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/immunology
9.
Food Funct ; 7(3): 1610-5, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26918250

ABSTRACT

In this paper, we have investigated the hypoglycemic and anti-inflammatory effects of seabuckthorn seed protein (SSP) on streptozocin (STZ)-induced diabetic IRC mice. The effects of SSP on the body weight (BW), fasting blood glucose (FBG) levels, serum lipids, inflammatory factors and insulin (SIN) levels of normal and diabetic mice have been investigated. SSP has been shown to reduce insulin resistance (IR) and control the effects of C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and nuclear factor-κ-gene binding (NF-κB). In addition, this paper further validates the hypoglycemic and anti-inflammatory effects of seabuckthorn procyanidins (SPR) and seabuckthorn polysaccharides (SPO) in diabetic mice and the experimental results were consistent with previous studies. Moreover, results from animal experiments showed that SSP has a significant hypoglycemic and anti-inflammatory effect as evidenced by the lower BW, FBG levels, SIN and lipid contents of diabetic mice treated with SSP compared to the diabetic control mice.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Diabetes Mellitus, Experimental/drug therapy , Hippophae/chemistry , Hypoglycemic Agents/administration & dosage , Plant Extracts/administration & dosage , Plant Proteins/administration & dosage , Animals , Blood Glucose/metabolism , Diabetes Mellitus, Experimental/genetics , Diabetes Mellitus, Experimental/metabolism , Humans , Insulin/metabolism , Interleukin-6/genetics , Interleukin-6/metabolism , Male , Mice , Mice, Inbred ICR , NF-kappa B/genetics , NF-kappa B/metabolism , Seeds/chemistry , Tumor Necrosis Factor-alpha/genetics , Tumor Necrosis Factor-alpha/metabolism
10.
Pak J Pharm Sci ; 27(4): 859-64, 2014 Jul.
Article in English | MEDLINE | ID: mdl-25015452

ABSTRACT

The antioxidant effects of the triterpenoid-rich extracts from Euryale ferox shell (ES) have been confirmed in vitro. This study examined whether the triterpenoid-rich extract from ES eases human hyperglycemia and diabetes caused by metabolic disorders. Normal and streptozocin (STZ)-induced diabetic mice were used as controls for the four groups that received the triterpenoid-rich extracts of ES suspended in distilled water orally at doses of 200, 300, 400, 500±2 mg/L. Body weight, blood glucose and pancreatic tissue morphology were observed after 4 weeks. The expression of protein tyrosine phosphatase-1B (PTP1B) and insulin receptor substrate (IRS-1) proteins, which are related to the regulation of glucose metabolism in vivo, were also investigated. Compared with the model group (LD50 900±2 mg/L), it was found that the triterpenoid-rich extracts of ES could regulate glucose metabolism (P<0.01) and cause body weight to return to normal levels (P<0.05). Islet morphology recovered well, the expression of the negative regulation protein PTP1B gene was reduced and insulin receptor IRS-1 protein expression was increased. These data prove that the triterpenoid-rich extracts from ES have a therapeutic effect on diabetes by insulin resistance.


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/pharmacology , Nymphaeaceae , Phytotherapy , Plant Extracts/pharmacology , Triterpenes/pharmacology , Animals , Diabetes Mellitus, Experimental/metabolism , Diabetes Mellitus, Experimental/pathology , Insulin Receptor Substrate Proteins/physiology , Male , Mice , Protein Tyrosine Phosphatase, Non-Receptor Type 1/physiology , Streptozocin
11.
Carbohydr Polym ; 103: 81-6, 2014 Mar 15.
Article in English | MEDLINE | ID: mdl-24528703

ABSTRACT

Hypoglycemic effects of indica rice resistant starch (IR-RS) were investigated. We prepared IR-RS using a method that combined physical modification and enzyme modification, and the RS content was 47.0%. Differential scanning calorimetry--thermal gravimetric analysis showed that IR-RS have higher enthalpy and less loss of mass than single modified RS, heat-moisture RS and native starch. Scanning electron microscopy revealed that IR-RS displayed more compact spatial structure. IR-RS products displayed a mixture of B-and V-type x-ray diffraction patterns and the cyrstallinity was 51.0%. IR-RS significantly affected body weight, blood glucose, organ indices and serum lipid levels. These results demonstrated that dual modification changed the structure of indica rice starch and affected its digestibility as well as the blood glucose levels of the diabetic mice who consumed it.

12.
Pharmazie ; 68(3): 227-31, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23556344

ABSTRACT

The hypoglycemic and hypolipidemic effects of a triterpenoid-rich extract from the Euryale shell (ES) was analyzed in streptozotocin-induced diabetic mice. Normal and diabetic mice treated with glimepiride were used as negative and positive controls, respectively. Body weight, organ weight index and cholesterol-related lipid profile parameters were observed after 4 weeks. The hypoglycemic activity was assessed by fasting blood glucose (FBG) and fasting insulin (FINS) to calculate the insulin sensitivity index (ISI). In addition, the potentially regulative mechanisms on insulin resistance were discussed. The results indicated that a triterpenoid-rich extract of ES could inhibit reduction in the body weight of diabetic mice and regulate glucose metabolism. The hypolipidemic action after this extract supplementation was confirmed by significant (p<0.05) decreases in the levels of cholesterol, LDL and triglycerides and increase in HDL compared with the untreated diabetic mice, especially when using a high dose, which suggested that the ES extract could effectively reverse the abnormal enlargement of the liver and spleen (p<0.01). The present data suggest that the triterpenoid-rich extract from the ES has both hypoglycemic and hypolipidemic effects that can not only help cure and manage diabetes but also improve insulin resistance (IR).


Subject(s)
Diabetes Mellitus, Experimental/drug therapy , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/therapeutic use , Plants, Medicinal/chemistry , Triterpenes/pharmacology , Animals , Blood Glucose/metabolism , Body Weight/drug effects , Diabetes Mellitus, Experimental/blood , Hypoglycemic Agents/chemistry , Hypolipidemic Agents/chemistry , Insulin/blood , Insulin Resistance , Lipids/blood , Male , Mice , Organ Size/drug effects , Seeds/chemistry , Triterpenes/chemistry
13.
Plant Physiol Biochem ; 47(4): 308-12, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19153049

ABSTRACT

The Arabidopsis Ethylene-Insensitive 2 (EIN2) gene has been shown to be involved in the regulation of abiotic and biotic stresses, including ozone stress, high salt, oxidative stress and disease resistance. However, little is known about the role of EIN2 gene in lead (Pb) resistance in Arabidopsis. In this study, we showed that EIN2 gene is required for Pb(II) resistance in Arabidopsis. EIN2 gene was induced by Pb(II) treatment, and the ein2-1 mutant showed enhanced sensitivity to Pb(II). A higher Pb content was detected in ein2-1 plants than in wild-type plants when subjected to Pb(II) treatment, which was associated, at least in part, with reduction in expression of AtPDR12 gene, a pump excluding Pb(II) and/or Pb(II)-containing toxic compounds from the cytoplasm. Moreover, the ein2-1 mutation also impaired glutathione (GSH)-dependent Pb(II) resistance, which was related to constitutive reduction of express of GSH1 gene involved in GSH synthesis and consequently reduced GSH content. Taken together, all these results suggest that EIN2 gene mediates Pb(II) resistance, at least in part, through two distinct mechanisms, a GSH-dependent mechanism and a GSH-independent AtPDR12-mediated mechanism.


Subject(s)
Arabidopsis Proteins/physiology , Arabidopsis/drug effects , Arabidopsis/metabolism , Lead/toxicity , Receptors, Cell Surface/physiology , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Gene Expression Regulation, Plant/drug effects , Gene Expression Regulation, Plant/genetics , Glutathione/metabolism , Plants, Genetically Modified/drug effects , Plants, Genetically Modified/genetics , Receptors, Cell Surface/genetics , Reverse Transcriptase Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL
...